Citable filing context
WTW's research view summarizes recent SEC filing context, starting with earnings from Jul 30, 2026.
| Filed | Item | Context |
|---|---|---|
| Jul 30, 2026 | earnings | WTW reported Q2 2026 revenue of $2.46 billion and increased its share repurchase authority by $1.5 billion. |
| May 21, 2026 | other | WTW shareholders approved director nominees, auditor selection, and an amended Employee Share Purchase Plan at the 2026 AGM. |
| Apr 30, 2026 | earnings | WTW reported Q1 2026 revenue of $2.4 billion and diluted EPS of $3.10, up 33% year-over-year. |
| Jul 30, 2026 | Guidance: adjusted_operating_margin | not reported to 30.00 |
| Jul 30, 2026 | Guidance: adjusted_operating_margin_expansion | not reported to 100.00 |
| Jul 30, 2026 | Guidance: newfront_acquisition_dilution | not reported to 0.10 |
| Jul 30, 2026 | mda_quarterly | WTW reported strong top-line growth for the second quarter of 2026, with consolidated revenue reaching $2.5 billion, a 9% increase on an as-reported basis and 5% organically. Growth was driven by both the Health, Wealth & Career (HWC) and Risk & Broking (R&B) segments. HWC benefited from retirement work and expanded project engagements, while R&B saw robust performance in corporate risk and software sales within its technology practice. Despite revenue gains, net income attributable to WTW declined 31% to $229 million for the quarter, largely due to increased salary and incentive costs, higher transaction and integration expenses related to the Newfront acquisition, and a higher effective tax rate compared to the prior-year period. Management noted that market conditions are generally softening, with the notable exception of U.S. Casualty and specific specialty lines. The company continues to prioritize investments in AI and data analytics to maintain competitive standards. Liquidity remains sufficient, supported by $1.6 billion in cash and full availability under a $1.5 billion revolving credit facility. During the first half of 2026, WTW deployed significant capital for the acquisitions of Newfront and Cushon, as well as $750 million in share repurchases, reflecting a disciplined approach to capital allocation despite ongoing macroeconomic volatility. |
| Apr 30, 2026 | mda_quarterly | WTW reported first-quarter 2026 revenue of $2.4 billion, an 8% as-reported increase driven by 3% organic growth and favorable currency translation from the Euro and Pound Sterling. Net income rose to $297 million, with adjusted operating margins expanding to 22.3%. The company is currently navigating a softening insurance market, which typically exerts downward pressure on commission revenue. Within the Health, Wealth & Career segment, organic growth in Health and Wealth was offset by declines in Career—attributed to geopolitical uncertainty in the Middle East and moderated North American advisory demand—and lower commissions in the Individual Marketplace. Conversely, the Risk & Broking segment saw organic growth fueled by strong software sales and corporate client retention. Strategic activity was highlighted by the acquisition of Newfront Insurance Holdings, funded via a $1.0 billion senior notes offering, and $300 million in share repurchases. Financial risks include persistent inflation, fluctuating interest rates, and geopolitical volatility. Liquidity remains stable, supported by a $1.5 billion revolving credit facility and a $775 million delayed draw term loan, though the company expects ongoing capital contributions to its reinsurance broking joint venture with Bain Capital. |
Source: SEC EDGAR filing text and events; period Jul 30, 2026; filed Jul 30, 2026.
WTW company research is available with Aerarium Pro (CAD $10/mo). The five showcase tickers (TSLA, NVDA, AAPL, AMZN, PLTR) and the macro dashboard stay free. Already a subscriber? Sign in to pick up where you left off.